Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Intraductal, Noninfiltrating × trastuzumab biosimilar HLX02 × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Salivary Gland Neoplasms 1 Malignant Solid Neoplasm 1 Lung Neoplasms 1 Inflammatory Breast Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1 Anatomic Stage II Breast Cancer AJCC v8 1 Anatomic Stage I Breast Cancer AJCC v8 1 Advanced Breast Carcinoma 1 Adenocarcinoma Of Esophagus 1

Interventions

Specimen Handling 7 Tamoxifen 6 exemestane 3 Letrozole 3 Anastrozole 3 Surveys and Questionnaires 2 Radiotherapy 2 Radiation Dose Hypofractionation 2 Observation 2 Biopsy 2 poly ICLC 1 fezolinetant 1 elacestrant 1 Testosterone 1 Surgical Procedures, Operative 1 Standard of Care 1 Sentinel Lymph Node Biopsy 1 Selective Estrogen Receptor Modulators 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiosurgery 1 Radiation 1 Practice Guidelines as Topic 1 Petrolatum 1 Patient Navigation 1 Nutrition Assessment 1 Neoadjuvant Therapy 1 Multicenter Studies as Topic 1 Methods 1 Metformin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡